DK2038423T3 - Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet - Google Patents

Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet

Info

Publication number
DK2038423T3
DK2038423T3 DK07805625.6T DK07805625T DK2038423T3 DK 2038423 T3 DK2038423 T3 DK 2038423T3 DK 07805625 T DK07805625 T DK 07805625T DK 2038423 T3 DK2038423 T3 DK 2038423T3
Authority
DK
Denmark
Prior art keywords
biologically active
active polypeptides
insulinotropic activity
preparing biologically
preparing
Prior art date
Application number
DK07805625.6T
Other languages
English (en)
Inventor
Kedarnath Nanjund Sastry
Akundi Venkata Sriram
Lakshmi Prabha Varadarajalu
Shrikumar Suryanarayan
Ramakrishnan Melarkode
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Application granted granted Critical
Publication of DK2038423T3 publication Critical patent/DK2038423T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK07805625.6T 2006-06-21 2007-06-20 Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet DK2038423T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1057CH2006 2006-06-21
PCT/IN2007/000241 WO2007148345A2 (en) 2006-06-21 2007-06-20 A method of producing biologically active polypeptide having insulinotropic activity

Publications (1)

Publication Number Publication Date
DK2038423T3 true DK2038423T3 (da) 2013-04-02

Family

ID=38833862

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07805625.6T DK2038423T3 (da) 2006-06-21 2007-06-20 Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet

Country Status (8)

Country Link
US (1) US8114632B2 (da)
EP (1) EP2038423B1 (da)
CN (1) CN101501209B (da)
DK (1) DK2038423T3 (da)
ES (1) ES2401856T3 (da)
PL (1) PL2038423T3 (da)
PT (1) PT2038423E (da)
WO (1) WO2007148345A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102725396A (zh) * 2009-10-30 2012-10-10 默沙东公司 在缺乏二肽基氨肽酶活性的巴斯德毕赤酵母中生产治疗性蛋白的方法
EP2494050A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme GRANULOCYTIC COLONY STIMULATING FACTOR MADE IN GLYCOENGINEERED PICHIA PASTORIS
ES2550761T3 (es) 2009-11-25 2015-11-12 Novo Nordisk A/S Método para producción de polipéptidos
WO2012152823A1 (en) 2011-05-09 2012-11-15 Ablynx Nv Method for the production of immunoglobulin single variable domains
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
AU2013366692B2 (en) 2012-12-21 2017-11-23 Sanofi Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists
CN103911388B (zh) * 2013-10-16 2017-06-06 东莞市麦亘生物科技有限公司 重组艾塞那肽的生产工艺
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
CN113462713B (zh) * 2021-09-06 2021-12-07 中国农业科学院生物技术研究所 提高胰高血糖素样肽六连体在毕赤酵母中表达水平的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
CA2258307C (en) * 1996-07-05 2008-02-12 Novo Nordisk A/S Method of producing heterologous short chain polypeptides by yeast with impaired yap3 protease
US6723530B1 (en) * 1997-02-05 2004-04-20 Amylin Pharmaceuticals, Inc. Polynucleotides encoding proexendin, and methods and uses thereof
WO1998035033A1 (en) 1997-02-05 1998-08-13 1149336 Ontario Inc. Polynucleotides encoding proexendin, and methods and uses thereof
ES2293688T5 (es) 1997-08-08 2011-05-04 Amylin Pharmaceuticals, Inc. Nuevos compuestos análogos de la exendina.
EP0978565B1 (en) 1998-01-30 2007-10-10 Asubio Pharma Co., Ltd. Process for producing peptide with the use of accessory peptide
MXPA02005014A (es) * 1999-11-19 2003-02-27 Transkaryotic Therapies Inc Constructo de acido nucleico para produccion optimizada de productos.
CN1363654A (zh) * 2001-07-19 2002-08-14 上海华谊生物技术有限公司 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法
CN1233816C (zh) * 2002-04-16 2005-12-28 海南海梁生物高科技有限公司 酵母重组株及IFNα-la干扰素的纯化方法
EP1626981A4 (en) * 2003-03-04 2006-11-22 Biorexis Pharmaceutical Corp PROTEINS PROTECTED AGAINST DIPEPTIDYLPEPTIDASE
CN1268751C (zh) * 2003-05-26 2006-08-09 海南国栋药物研究所有限公司 表达人粒细胞巨噬细胞集落刺激因子的酵母重组株及rhGM-CSF的纯化方法
WO2005100388A1 (en) * 2004-04-19 2005-10-27 Biocon Limited Production of insulinotropic peptides
CN1318587C (zh) * 2004-04-30 2007-05-30 成都芝田生物工程有限公司 酰胺化Exendin-4多肽的重组制备方法
CN100535111C (zh) 2004-11-03 2009-09-02 东莞太力生物工程有限公司 一种制备重组Exendin-4多肽的新工艺

Also Published As

Publication number Publication date
EP2038423A4 (en) 2009-12-09
HK1132011A1 (en) 2010-02-12
US8114632B2 (en) 2012-02-14
EP2038423B1 (en) 2012-12-26
CN101501209A (zh) 2009-08-05
US20100167342A1 (en) 2010-07-01
EP2038423A2 (en) 2009-03-25
ES2401856T3 (es) 2013-04-25
WO2007148345A3 (en) 2008-02-07
CN101501209B (zh) 2013-06-05
WO2007148345A2 (en) 2007-12-27
PT2038423E (pt) 2013-03-27
PL2038423T3 (pl) 2013-05-31

Similar Documents

Publication Publication Date Title
DK2038423T3 (da) Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet
DK2046819T3 (da) Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
DK2044002T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DK2602263T3 (da) Polypeptider omfattende en isbindende aktivitet
DK2139987T3 (da) Fremgangsmåder til proteinfremstilling med anti-senescens-forbindelser
DK2054042T3 (da) Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
NO20082564L (no) Hepatosyttvekstfaktorintronfusjonsproteiner
DE602007001492D1 (de) Schubkraftkorrektur
DK2343362T4 (da) Forbedret fremgangsmåde til dyrkning af celler
DK2043583T3 (da) Patientstøtte med svejsede materialer
EP2467097A4 (en) POROUS IMPLANT STRUCTURES
EP2044907A4 (en) STENT
DK3115370T3 (da) Biologisk aktive peptider
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
IL192619A0 (en) Method for preparing 3-hydroxytetrahydrofuran using cyclodehydration
EP2001923A4 (en) BIOSTABILE POLYURETHANE
DE602007000311D1 (de) Sitzstützstruktur
FR2908035B1 (fr) Implant interepineux
DE602007008831D1 (de) Cyclohexyl-sulfonamid-derivate mit h3-rezeptoraktivität
EP2077099A4 (en) STENT
EP1982145A4 (en) ALIGNMENT CORRECTION SYSTEM AND METHODS OF USE
DK1952103T3 (da) Fremgangsmåde til at veje med flere vejeceller
NO20060919L (no) Boyle til barnestol
BRPI0820538A2 (pt) Isoformas de neuregulina solúveis ativas modificadas pós-traducionalmente
DK2019135T3 (da) Fremgangsmåde til genvinding af lipaseaktivitet